Mortality Associated with Resistant Cytomegalovirus among Patients with Cytomegalovirus Retinitis and AIDS

Douglas Jabs, Barbara K. Martin, Michael S. Forman

Research output: Contribution to journalArticle

Abstract

Objective: To evaluate the effect of drug-resistant cytomegalovirus (CMV) on survival among patients with CMV retinitis. Design: Prospective cohort study during 1993 to 2003. Participants: We included 266 patients with AIDS and newly diagnosed CMV retinitis treated with either ganciclovir or foscarnet. Methods: Data on ganciclovir and foscarnet resistance were obtained from blood and urine specimens collected at regular, predetermined intervals. The effect of resistant CMV on mortality was evaluated with a time-dependent Cox proportional hazard model. Main Outcome Measures: Mortality. Results: The median survival of the entire cohort was 12.6 months. Analysis of risk factors for mortality demonstrated that resistant CMV was associated with an increased mortality (hazard ratio, 1.65; 95% confidence interval, 1.05-2.56; P = 0.032). Among the other parameters tested, only time since AIDS diagnosis was associated significantly with mortality, with a hazard ratio of 1.10 per year since AIDS diagnosis (P = 0.001). Conclusions: Resistant CMV is associated with increased mortality among patients with AIDS being treated for CMV retinitis. Financial Disclosure(s): Proprietary or commercial disclosure may be found after the references.

Original languageEnglish (US)
JournalOphthalmology
Volume117
Issue number1
DOIs
StatePublished - Jan 1 2010

Fingerprint

Cytomegalovirus Retinitis
Cytomegalovirus
Acquired Immunodeficiency Syndrome
Mortality
Foscarnet
Ganciclovir
Disclosure
Survival
Proportional Hazards Models
Cohort Studies
Outcome Assessment (Health Care)
Urine
Prospective Studies
Confidence Intervals
Pharmaceutical Preparations

ASJC Scopus subject areas

  • Ophthalmology

Cite this

Mortality Associated with Resistant Cytomegalovirus among Patients with Cytomegalovirus Retinitis and AIDS. / Jabs, Douglas; Martin, Barbara K.; Forman, Michael S.

In: Ophthalmology, Vol. 117, No. 1, 01.01.2010.

Research output: Contribution to journalArticle

@article{a845860eeec14b18bab3920f4876da16,
title = "Mortality Associated with Resistant Cytomegalovirus among Patients with Cytomegalovirus Retinitis and AIDS",
abstract = "Objective: To evaluate the effect of drug-resistant cytomegalovirus (CMV) on survival among patients with CMV retinitis. Design: Prospective cohort study during 1993 to 2003. Participants: We included 266 patients with AIDS and newly diagnosed CMV retinitis treated with either ganciclovir or foscarnet. Methods: Data on ganciclovir and foscarnet resistance were obtained from blood and urine specimens collected at regular, predetermined intervals. The effect of resistant CMV on mortality was evaluated with a time-dependent Cox proportional hazard model. Main Outcome Measures: Mortality. Results: The median survival of the entire cohort was 12.6 months. Analysis of risk factors for mortality demonstrated that resistant CMV was associated with an increased mortality (hazard ratio, 1.65; 95{\%} confidence interval, 1.05-2.56; P = 0.032). Among the other parameters tested, only time since AIDS diagnosis was associated significantly with mortality, with a hazard ratio of 1.10 per year since AIDS diagnosis (P = 0.001). Conclusions: Resistant CMV is associated with increased mortality among patients with AIDS being treated for CMV retinitis. Financial Disclosure(s): Proprietary or commercial disclosure may be found after the references.",
author = "Douglas Jabs and Martin, {Barbara K.} and Forman, {Michael S.}",
year = "2010",
month = "1",
day = "1",
doi = "10.1016/j.ophtha.2009.06.016",
language = "English (US)",
volume = "117",
journal = "Ophthalmology",
issn = "0161-6420",
publisher = "Elsevier Inc.",
number = "1",

}

TY - JOUR

T1 - Mortality Associated with Resistant Cytomegalovirus among Patients with Cytomegalovirus Retinitis and AIDS

AU - Jabs, Douglas

AU - Martin, Barbara K.

AU - Forman, Michael S.

PY - 2010/1/1

Y1 - 2010/1/1

N2 - Objective: To evaluate the effect of drug-resistant cytomegalovirus (CMV) on survival among patients with CMV retinitis. Design: Prospective cohort study during 1993 to 2003. Participants: We included 266 patients with AIDS and newly diagnosed CMV retinitis treated with either ganciclovir or foscarnet. Methods: Data on ganciclovir and foscarnet resistance were obtained from blood and urine specimens collected at regular, predetermined intervals. The effect of resistant CMV on mortality was evaluated with a time-dependent Cox proportional hazard model. Main Outcome Measures: Mortality. Results: The median survival of the entire cohort was 12.6 months. Analysis of risk factors for mortality demonstrated that resistant CMV was associated with an increased mortality (hazard ratio, 1.65; 95% confidence interval, 1.05-2.56; P = 0.032). Among the other parameters tested, only time since AIDS diagnosis was associated significantly with mortality, with a hazard ratio of 1.10 per year since AIDS diagnosis (P = 0.001). Conclusions: Resistant CMV is associated with increased mortality among patients with AIDS being treated for CMV retinitis. Financial Disclosure(s): Proprietary or commercial disclosure may be found after the references.

AB - Objective: To evaluate the effect of drug-resistant cytomegalovirus (CMV) on survival among patients with CMV retinitis. Design: Prospective cohort study during 1993 to 2003. Participants: We included 266 patients with AIDS and newly diagnosed CMV retinitis treated with either ganciclovir or foscarnet. Methods: Data on ganciclovir and foscarnet resistance were obtained from blood and urine specimens collected at regular, predetermined intervals. The effect of resistant CMV on mortality was evaluated with a time-dependent Cox proportional hazard model. Main Outcome Measures: Mortality. Results: The median survival of the entire cohort was 12.6 months. Analysis of risk factors for mortality demonstrated that resistant CMV was associated with an increased mortality (hazard ratio, 1.65; 95% confidence interval, 1.05-2.56; P = 0.032). Among the other parameters tested, only time since AIDS diagnosis was associated significantly with mortality, with a hazard ratio of 1.10 per year since AIDS diagnosis (P = 0.001). Conclusions: Resistant CMV is associated with increased mortality among patients with AIDS being treated for CMV retinitis. Financial Disclosure(s): Proprietary or commercial disclosure may be found after the references.

UR - http://www.scopus.com/inward/record.url?scp=72749115421&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=72749115421&partnerID=8YFLogxK

U2 - 10.1016/j.ophtha.2009.06.016

DO - 10.1016/j.ophtha.2009.06.016

M3 - Article

C2 - 19818505

AN - SCOPUS:72749115421

VL - 117

JO - Ophthalmology

JF - Ophthalmology

SN - 0161-6420

IS - 1

ER -